整合生物样本库资源揭示了调节特应性皮炎易感性的新遗传途径。

Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis.

作者信息

Sliz Eeva, Huilaja Laura, Pasanen Anu, Laisk Triin, Reimann Ene, Mägi Reedik, Hannula-Jouppi Katariina, Peltonen Sirkku, Salmi Teea, Koulu Leena, Tasanen Kaisa, Kettunen Johannes

机构信息

Center for Life Course Health Research, Faculty of Medicine, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland.

Department of Dermatology, PEDEGO Research Unit, Medical Research Center Oulu, Oulu, Finland; University Hospital and University of Oulu, Oulu, Finland.

出版信息

J Allergy Clin Immunol. 2022 Mar;149(3):1105-1112.e9. doi: 10.1016/j.jaci.2021.07.043. Epub 2021 Aug 27.

Abstract

BACKGROUND

Atopic dermatitis (AD) is a common chronic inflammatory skin disease with high heritability. Previous genome-wide association studies have identified several loci predisposing to AD. These findings explain approximately 30% of the variance in AD susceptibility, suggesting that further work is required to fully understand the genetic underpinnings.

OBJECTIVE

We sought to gain additional understanding of the genetic contribution to AD risk by using biobank resources.

METHODS

We completed a genome-wide meta-analysis of AD in 796,661 individuals (N = 22,474) from the FinnGen study, the Estonian Biobank, and the UK Biobank. We further performed downstream in silico analyses to characterize the risk variants at the novel loci.

RESULTS

We report 30 loci associating with AD (P < 5 × 10), 5 of which are novel. In 2 of the novel loci, we identified missense mutations with deleterious predictions in desmocollin 1 and serpin family B member 7, genes encoding proteins crucial to epidermal strength and integrity.

CONCLUSIONS

These findings elucidate novel genetic pathways involved in AD pathophysiology. The likely involvement of desmocollin 1 and serpin family B member 7 in AD pathogenesis may offer opportunities for the development of novel treatment strategies for AD in the future.

摘要

背景

特应性皮炎(AD)是一种常见的具有高遗传度的慢性炎症性皮肤病。既往全基因组关联研究已经确定了几个易患AD的基因座。这些发现解释了AD易感性中约30%的变异,这表明需要进一步开展工作以充分理解其遗传基础。

目的

我们试图通过利用生物样本库资源来进一步了解遗传因素对AD风险的影响。

方法

我们对来自芬兰基因研究、爱沙尼亚生物样本库和英国生物样本库的796,661名个体(N = 22,474)的AD进行了全基因组荟萃分析。我们进一步进行了下游的电子分析,以表征新基因座处的风险变异。

结果

我们报告了30个与AD相关的基因座(P < 5×10),其中5个是新发现的。在2个新基因座中,我们在桥粒芯蛋白1和丝氨酸蛋白酶抑制剂家族B成员7中鉴定出具有有害预测的错义突变,这些基因编码对表皮强度和完整性至关重要的蛋白质。

结论

这些发现阐明了参与AD病理生理学的新遗传途径。桥粒芯蛋白1和丝氨酸蛋白酶抑制剂家族B成员7可能参与AD发病机制,这可能为未来开发AD的新型治疗策略提供机会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索